此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Senior Peer Alliance for Rural Research On Wellness (SPARROW)

2019年7月30日 更新者:University of California, San Francisco

Case Management and Problem Solving Therapy for Depressed Older Adults

Dr. Brooke Hollister, Ph.D. from the department of Social and Behavioral Sciences at the University of California, San Francisco is conducting a study comparing two types of interventions for treating depression in rural older adults.

研究概览

地位

完全的

条件

详细说明

If you are eligible to participate in the study after completing the screening assessment, and if you choose to continue on, we will randomize you (like a flip of a coin) to receive either 12 weeks of case management combined with problem solving therapy (CM-PST) with a social worker or 12 weeks of self-guided problem solving therapy (SG-PST) with support from a senior peer counselor.

As part of your participation in the study you will participate in three 1.5 hour assessment interviews of psychological and neuropsychological functioning (similar to your screening assessment) prior to your first week of treatment (baseline), two weeks after your final session (week 14), and three months after your final session (week 24). Additionally, you will participate in three shorter assessment interviews of psychological functioning, which will be conducted at weeks 3 and 6. These assessments will take approximately 30-45 minutes.

研究类型

介入性

注册 (实际的)

105

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • California
      • Sonora、California、美国、95370
        • Catholic Charities Motherlode Office- Sonora

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

60年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Residence in rural Tuolumne, Calaveras, San Joaquin or Stanislaus Counties;
  • Diagnosis: Major depression, unipolar (by SCID ascertained DSM-IV criteria);
  • Severity of depression: A PHQ-9>10 or a 24-Item HDRS>19;
  • Need for social services: CANE score> 2, i.e. at least one unmet need;

Exclusion Criteria:

  • Psychotic depression by SCID-IV, i.e., presence of delusions;
  • High suicide risk, i.e. intent or plan to attempt suicide in near future;
  • Presence of any Axis I psychiatric disorder or substance abuse other than unipolar major depression;
  • Axis II diagnosis of antisocial personality (by SCID-P and DSM-IV);
  • History of psychiatric disorders other than unipolar major depression or generalized anxiety disorder (including bipolar disorder, hypomania, and dysthymia);
  • Dementia: MMSE below 24 or clinical diagnosis of dementia by DSM-IV;
  • Acute/severe medical illness (delirium, metastatic cancer, de-compensated cardiac, liver or kidney failure, stroke or myocardial infarction) 3 months prior to entry; or use of drugs causing depression, (steroids, reserpine, alphamethyl-dopa, tamoxiphen, vincristine);
  • Inability to perform any of the ADLs (MAI: ADL subscale) even with assistance (walking with a cane is not an exclusion criterion)
  • Inability to speak English;
  • Aphasia interfering with communication;

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:CM-PST
If you are assigned to CM-PST, you will be working with the same care manager from your introductory session. The care manager will continue to work with you on your problem-solving plan. Additionally, you will receive case management services.
实验性的:SG-PST
If you are assigned to SG-PST, you will continue to work on your problem-solving plan, using the self-guided materials provided to you during the introductory session. Additionally, you will be partnered with a senior peer counselor who will support you in your SG-PST efforts.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Hamilton Rating Scale for Depression (HRSD)
大体时间:Baseline
A multiple item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery.
Baseline
Hamilton Rating Scale for Depression (HRSD)
大体时间:Week 3
A multiple item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery.
Week 3
Hamilton Rating Scale for Depression (HRSD)
大体时间:Week 6
A multiple item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery.
Week 6
Hamilton Rating Scale for Depression (HRSD)
大体时间:Week 12
A multiple item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery.
Week 12
WHO Disability Assessment Schedule 2.0 (WHODAS-II)
大体时间:Week 0
Generic assessment instrument for health and disability
Week 0
WHO Disability Assessment Schedule 2.0 (WHODAS-II)
大体时间:Week 3
Generic assessment instrument for health and disability
Week 3
WHO Disability Assessment Schedule 2.0 (WHODAS-II)
大体时间:Week 6
Generic assessment instrument for health and disability
Week 6
WHO Disability Assessment Schedule 2.0 (WHODAS-II)
大体时间:Week 12
Generic assessment instrument for health and disability
Week 12

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Brooke Hollister, Ph.D.、University of California, San Francisco
  • 首席研究员:Patricia Arean, Ph.D.、University of California, San Francisco

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2013年8月1日

初级完成 (实际的)

2018年8月1日

研究完成 (实际的)

2019年3月31日

研究注册日期

首次提交

2013年7月29日

首先提交符合 QC 标准的

2013年7月29日

首次发布 (估计)

2013年8月1日

研究记录更新

最后更新发布 (实际的)

2019年7月31日

上次提交的符合 QC 标准的更新

2019年7月30日

最后验证

2019年7月1日

更多信息

与本研究相关的术语

其他研究编号

  • R01AG043584-01A1 (美国 NIH 拨款/合同)

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

医学博士的临床试验

CM-PST的临床试验

3
订阅